Loading company details...
Beta
Latest Form 4 (Oct 9, 2026): Tao Fu (President and CEO): Grant/Award of 538,300 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Tao Fu, President and CEO | Grant/Award | 538,300 | n/a |
| Oct 9, 2026 | Steven Chan, Chief Financial Officer | Grant/Award | 140,000 | n/a |
| Aug 28, 2026 | Colin Walsh | Purchase | 85,000 | $1.78M |
| Aug 28, 2026 | GOLDMAN SACHS GROUP INC | Purchase | 85,000 | $1.78M |
| Aug 10, 2026 | venBio Global Strategic Fund IV, L.P. | Conversion | 2,311,870 | n/a |
| Aug 8, 2026 | Redmile Group, LLC | Conversion | 782,854 | n/a |
| Aug 7, 2026 | Sanofi | Conversion | 782,855 | n/a |
| Aug 6, 2026 | Frazier Life Sciences XI, L.P. | Conversion | 1,749,192 | n/a |
| Aug 6, 2026 | Angie You | Grant/Award | 27,000 | n/a |
| Aug 6, 2026 | Mitchell Gold | Grant/Award | 27,000 | n/a |